Markie - this extract from the announcement this morning:
Column 1 1 Settlement issues
Despite the fact that securities are trading ‘ex entitlement’ on ASX Trade, CHESS will not recognise for settlement purposes the ‘ex entitlement’ or the ‘cum entitlement’ tag on CHESS messages and CHESS will not maintain cum balances during the deemed ‘CHESS ex-period’, i.e. the period commencing on the deemed CHESS ex-date up to and including the record date. However, a record date cum balance will be available the business day following the record date, which will be equal to the registered holding balance at CHESS end of day on the record date. As a result any transfer that occurs prior to record date will be effectively transferred on a ‘cum’ basis.
You might be right and I hope you are, really just wanting to clarify I suppose.
- Forums
- ASX - By Stock
- MYR
- Ann: Myer Full Year Results (FY2015) Release & Entitlement Offer
MYR
myer holdings limited
Add to My Watchlist
1.65%
!
61.5¢

Ann: Myer Full Year Results (FY2015) Release & Entitlement Offer, page-35
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
61.5¢ |
Change
0.010(1.65%) |
Mkt cap ! $1.062B |
Open | High | Low | Value | Volume |
60.0¢ | 62.5¢ | 59.8¢ | $3.415M | 5.582M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 19696 | 61.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
62.5¢ | 92228 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6118 | 0.605 |
13 | 319011 | 0.600 |
7 | 60403 | 0.595 |
18 | 222579 | 0.590 |
10 | 91829 | 0.585 |
Price($) | Vol. | No. |
---|---|---|
0.630 | 120060 | 4 |
0.635 | 66114 | 2 |
0.640 | 8130 | 1 |
0.645 | 10000 | 1 |
0.650 | 91182 | 7 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
MYR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online